Stock & Company Details
Glaukos Corporation $GKOS
Price:
46,691,331
59M
$9.1B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-42.84
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
GKOS technical indicators
Latest Glaukos Corporation (GKOS) technical indicators as of 2026-07-17: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
69.50 1.8%
MACD:
7.22 0.1%
SMA 50:
$134.45 0.3%
SMA 200:
$113.63 0.3%
EMA 20:
$146.74 0.7%
Bollinger Bands:
163 / 129
Stochastic:
84.40 0.4%
ADX 14:
21.72 3.5%
ATR 14:
6.40 0.8%
CCI 20:
92.05 21.1%
OBV:
6.41M 6.2%
ROC 12:
12.21% 31.6%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
Finance Bot
Ask your questions
Start by typing a question below.
